Highlights Sirona Biochem Corp.

Equities

SBM

CA82967M1005

Market Closed - Toronto S.E. Other stock markets 08:33:04 24/06/2024 pm IST			5-day change	1st Jan Change
0.05 ^CAD	0.00%		-9.09%	-58.33%

20/06	Sirona Biochem Corp. Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2024	CI
07/05	Sirona Biochem Engages Stonegate Healthcare Partners	CI

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Sirona Biochem Corp. Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2024	21/06	CI
Sirona Biochem Engages Stonegate Healthcare Partners	07/05	CI
Sirona Biochem Provides Update on Anti-Aging Product	08/04	MT
Sirona Biochem Corp. Reports Earnings Results for the First Quarter Ended January 31, 2024	01/04	CI
Sirona Biochem Corp. Reports Earnings Results for the Full Year Ended October 31, 2023	29/02	CI
Sirona Biochem Provides Corporate Update	24/01	MT
Sirona Biochem Launches Cosmetics Subsidiary	15/01	MT
Sirona Biochem Corp. Introduces A Wholly-Owned Subsidiary Sirona Laboratories	15/01	CI
Sirona Biochem Initiates GlycoProteMim Trademark for Anti-Aging Molecule TFC-1326	11/12	MT
Sirona Biochem Corp. Initiates GlycoProteMim?? Trademark for Anti-Aging Molecule TFC-1326	11/12	CI
Sirona Biochem Corp. Announces the Results of Its Research Collaboration with the International Centre for Genetic Engineering and Biotechnology in Advancing Sirona's Antiviral Compound Library	29/11	CI
Sirona Biochem Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2023	29/23/29	CI
Sirona Biochem Provides Strategic Review Update	13/23/13	MT
Sirona Biochem Corp. Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2023	30/23/30	CI
Sirona Biochem Advances Antiviral Research with New Compound Candidates for Testing At the ICGEB	28/23/28	CI
Sirona Biochem Announces Exceptional Clinical Trial Results for Anti-Aging Compound TFC-1326	25/23/25	CI
Sirona Biochem Corp. Reports Earnings Results for the First Quarter Ended January 31, 2023	30/23/30	CI
Sirona Biochem Corp. Reports Earnings Results for the Full Year Ended October 31, 2022	01/23/01	CI
Sirona Biochem Reports on Antiviral Testing Results	27/23/27	MT
Sirona Biochem Corp. Receives Results from its Research Collaboration with International Centre for Genetic Engineering and Biotechnology	27/23/27	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Sirona Biochem Corp.

Equities

SBM

CA82967M1005

Highlights

Filters